Salvational Intervention for Reducing AECOPD Under Severe Air Pollution

NACompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

March 16, 2022

Study Completion Date

March 16, 2022

Conditions
COPD ExacerbationAir Pollution
Interventions
DRUG

Budesonide/formoterol

On the foundation of basic treatment strategies, inhaled budesonide/formoterol(160ug/4.5ug)will be used as an intervention drug for patients in PIC group. When air quality index (AQI) is above 200, they will temporary add one inhalation of budesonide/formoterol(160ug/4.5ug)twice a day until the third day after AQI drops below 200.

DRUG

tiotropium bromide

Inhaled tiotropium bromide(18ug) will be used as routine medicine according to doctor's advice.

Trial Locations (11)

100034

Peking University First Hospital, Beijing

Unknown

Aerospace 731 Hospital, Beijing

Beijing Changping Hospital, Beijing

Beijing Jingmei Group General Hospital, Beijing

Beijing Jishuitan Hospital, Beijing

Beijing Luhe Hospital, Beijing

Beijing Miyun Hospital, Beijing

Civil Aviation General Hospital, Beijing

Peking University Shougang Hospital, Beijing

People's Hospital of Beijing Daxing District, Beijing

The Hospital of Shunyi District Beijing, Beijing

All Listed Sponsors
collaborator

Peking University Shougang Hospital

OTHER

collaborator

People's Hospital of Beijing Daxing District

OTHER

collaborator

Beijing Jingmei Group General Hospital

UNKNOWN

collaborator

Beijing Miyun Hospital

UNKNOWN

collaborator

The Hospital of Shunyi District Beijing

UNKNOWN

collaborator

Beijing Luhe Hospital

OTHER

collaborator

Civil Aviation General Hospital

OTHER

collaborator

Beijing Jishuitan Hospital

OTHER

collaborator

Aerospace 731 Hospital

OTHER

collaborator

Beijing Changping Hospital

UNKNOWN

lead

Peking University First Hospital

OTHER

NCT03083067 - Salvational Intervention for Reducing AECOPD Under Severe Air Pollution | Biotech Hunter | Biotech Hunter